HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.

Abstract
Runt domain transcription factor 3 (RUNX3) is widely regarded as a tumour-suppressor gene inactivated by DNA hypermethylation of its canonical CpG (cytidine-phosphate-guanidine) island (CGI) promoter in gastric cancer (GC). Absence of RUNX3 expression from normal gastric epithelial cells (GECs), the progenitors to GC, coupled with frequent RUNX3 overexpression in GC progression, challenge this longstanding paradigm. However, epigenetic models to better describe RUNX3 deregulation in GC have not emerged. Here, we identify lineage-specific DNA methylation at an alternate, non-CGI promoter (P1) as a new mechanism of RUNX3 epigenetic control. In normal GECs, P1 was hypermethylated and repressed, whereas in immune lineages P1 was hypomethylated and widely expressed. In human GC development, we detected aberrant P1 hypomethylation signatures associated with the early inflammatory, preneoplastic and tumour stages. Aberrant P1 hypomethylation was fully recapitulated in mouse models of gastric inflammation and tumorigenesis. Cell sorting showed that P1 hypomethylation reflects altered cell-type composition of the gastric epithelium/tumour microenvironment caused by immune cell recruitment, not methylation loss. Finally, via long-term culture of gastric tumour epithelium, we revealed that de novo methylation of the RUNX3 canonical CGI promoter is a bystander effect of oncogenic immortalization and not likely causal in GC pathogenesis as previously argued. We propose a new model of RUNX3 epigenetic control in cancer, based on immune-specific, non-CGI promoter hypomethylation. This novel epigenetic signature may have utility in early detection of GC and possibly other epithelial cancers with premalignant immune involvement.
AuthorsB Kurklu, R H Whitehead, E K Ong, T Minamoto, J G Fox, J R Mann, L M Judd, A S Giraud, T R Menheniott
JournalOncogene (Oncogene) Vol. 34 Issue 22 Pg. 2856-66 (May 28 2015) ISSN: 1476-5594 [Electronic] England
PMID25088199 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Core Binding Factor Alpha 3 Subunit
  • Runx3 protein, human
Topics
  • Animals
  • Cell Lineage (genetics)
  • Cell Transformation, Neoplastic (genetics, immunology)
  • Cells, Cultured
  • Core Binding Factor Alpha 3 Subunit (genetics)
  • CpG Islands
  • DNA Methylation
  • Gastric Mucosa (immunology, metabolism, pathology)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Organ Specificity (genetics, immunology)
  • Precancerous Conditions (genetics, immunology)
  • Promoter Regions, Genetic
  • Stomach Neoplasms (genetics, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: